Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Ovarian Neoplasms 2Carcinoma, Ovarian Epithelial 2Urinary Bladder Neoplasms 1Urethral Neoplasms 1Small Cell Lung Carcinoma 1Lung Neoplasms 1Gliosarcoma 1Glioblastoma 1Central Nervous System Neoplasms 1

Interventions

Radiotherapy 13Temozolomide 12Carmustine 5Chemotherapy, Adjuvant 3Radiosurgery 2Radiation 2Immunohistochemistry 2Everolimus 2Bevacizumab 2veliparib 1vatalanib 1sagopilone 1rubitecan 1mercaptoundecahydrododecaborate 1lonafarnib 1imetelstat 1beta-D-glucosylisophosphoramide mustard 1azurin (50-77) 1Tamoxifen 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Proton Therapy 1Perfusion Magnetic Resonance Imaging 1O(6)-benzylguanine 1Microarray Analysis 1Methotrexate 1Lomustine 1Leucovorin 1Irinotecan 1In Situ Hybridization, Fluorescence 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Gliosarcoma × rubitecan × Clear all
NCT00005826 2012-09-24

Nitrocamptothecin in Treating Patients With Glioblastoma Multiforme

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
17 enrolled
CNSSarcoma

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡